Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Vet Clin North Am Equine Pract ; 39(1): 89-98, 2023 Apr.
Article in English | MEDLINE | ID: mdl-36737284

ABSTRACT

Hendra virus (HeV) emerged as a zoonotic pathogen in the 1990s, causing low morbidity but high mortality in humans and horses. Pteropid bats are the natural reservoir of HeV and other important zoonotic viruses such as Nipah and Ebola viruses. Equivac HeV, manufactured by Zoetis (Parkville, Victoria, Australia), is the only commercially available vaccine for horses. There is no commercial vaccine for humans. The epidemiology, clinical features, pathology, diagnosis, management, and prevention of HeV will be reviewed.


Subject(s)
Chiroptera , Hendra Virus , Henipavirus Infections , Horse Diseases , Vaccines , Humans , Animals , Horses , Biosecurity , Horse Diseases/prevention & control , Vaccination/veterinary , Henipavirus Infections/epidemiology , Henipavirus Infections/veterinary
2.
J Vet Intern Med ; 37(6): 2535-2543, 2023.
Article in English | MEDLINE | ID: mdl-37800408

ABSTRACT

BACKGROUND: Right dorsal colitis (RDC) is a nonsteroidal anti-inflammatory drug (NSAID) induced, protein losing enteropathy in horses associated with a high case fatality rate. OBJECTIVES: To describe signalment, NSAID usage, clinical presentations, clinical pathology, ultrasonographic findings, treatments, outcomes, and factors associated with survival in horses diagnosed with RDC. ANIMALS: Thirty-five horses from 7 Australian equine hospitals diagnosed with RDC. METHODS: Retrospective case series. Clinical records of cases were accepted if definitively or presumptively diagnosed by an internist with RDC and had ≥3 of: hypoproteinemia or hypoalbuminemia; diarrhea with negative test results for infectious diseases; colic for which other diseases were excluded or right dorsal colon thickening on ultrasound. Descriptive data analysis was performed for categorical and continuous variables. Univariate binominal logistic regressions were used to assess factors associated with survival. RESULTS: An overdose of NSAIDs occurred in 84% (21/25) cases where dose was known. Common clinical presentations included diarrhea (69%; 22/32), colic (61%; 20/33), and tachycardia (53%, 17/32). Common clinicopathological findings included hypoalbuminemia (83%; 26/31), hypocalcaemia (79%, 23/29), and hyperlactatemia (77%, 14/18). The right dorsal colon wall appeared subjectively thickened in 77% (24/31) cases using ultrasonography. Case fatality rate was 43% (15/35). Odds of survival significantly decreased with increasing heart rate (odds 0.84, 95% CI = 0.71-0.92, P = .01), packed cell volume (odds 0.91, 95% CI 0.82-0.98, P = .05) and abnormal appearance of mucous membranes (odds 0.05, 95% CI 0.005-0.28, P = .001) on hospital presentation. CONCLUSIONS AND CLINICAL IMPORTANCE: An overdose of NSAIDs is common in horses diagnosed with RDC. Serum albumin concentrations should be monitored in horses receiving a prolonged course of NSAIDs. Overall prognosis for RDC remains fair.


Subject(s)
Colic , Colitis , Horse Diseases , Hypoalbuminemia , Animals , Horses , Retrospective Studies , Colic/veterinary , Phenylbutazone/adverse effects , Hypoalbuminemia/veterinary , Horse Diseases/diagnostic imaging , Horse Diseases/drug therapy , Horse Diseases/chemically induced , Australia , Colitis/veterinary , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Diarrhea/veterinary
3.
J Vet Intern Med ; 35(1): 571-579, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33284465

ABSTRACT

BACKGROUND: Grading of equine gastric ulcer syndrome (EGUS) is undertaken in clinical and research settings, but the reliability of EGUS grading systems is poorly understood. HYPOTHESIS/OBJECTIVES: Investigate interobserver and intraobserver reliability of an established ordinal grading system and a novel visual analog scale (VAS), and assess the influence of observer experience. ANIMALS: Sixty deidentified gastroscopy videos. METHODS: Six observers (3 specialists and 3 residents) graded videos using the EGUS Council (EGUC) system and VAS. Observers graded the videos three 3 for each system, using a cross-over design with at least 1 week between each phase. The order of videos was randomized for each phase. METHODS: Interobserver and intraobserver reliability were estimated using Gwet's agreement coefficient with ordinal weights applied (AC2) for the EGUC system and the intraclass correlation coefficient (ICC) for the VAS. RESULTS: Using the EGUC system, interobserver reliability was substantial for squamous (AC2 = 0.69; 95% confidence interval [CI], 0.57-0.80) and glandular mucosa (AC2 = 0.72; 95% CI, 0.70-0.75), and intraobserver reliability was substantial for squamous (AC2 = 0.80; 95% CI, 0.71-0.90) and glandular mucosa (AC2 = 0.80; 95% CI, 0.74-0.86). Interobserver reliability using the VAS was moderate for squamous (ICC = 0.64; 95% CI, 0.31-0.96) and poor for glandular mucosa (ICC = 0.35; 95% CI, 0.06-0.64), and intraobserver reliability was moderate for squamous (ICC = 0.74; 95% CI, 0.62-0.86) and glandular mucosa (ICC = 0.56; 95% CI, 0.39-0.72). CONCLUSIONS AND CLINICAL IMPORTANCE: The EGUC system had acceptable intraobserver and interobserver reliability and performed well regardless of observer experience. Familiarity and observer experience improved reliability of the VAS.


Subject(s)
Horse Diseases , Stomach Ulcer , Animals , Gastroscopy/veterinary , Horse Diseases/diagnosis , Horses , Humans , Observer Variation , Reproducibility of Results , Stomach Ulcer/diagnosis , Stomach Ulcer/veterinary
4.
J Vet Intern Med ; 35(1): 620-631, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33340169

ABSTRACT

BACKGROUND: Omeprazole preparations vary in bioavailability in horses. HYPOTHESIS/OBJECTIVES: To characterize the pharmacokinetics and pharmacodynamics of an existing enteric-coated oral omeprazole paste (REF) and a novel, in-feed, enteric-coated dry granule preparation (NOV). ANIMALS: Twelve Standardbred/Thoroughbred mares free from clinical disease. METHODS: A prospective, blinded randomized interventional study was trial, conducted in 3 parts: (a) bioavailability study, (b) dose titration study, and (c) comparative clinical pharmacodynamic study, each using a blocked crossover design. RESULTS: Consistent with the larger dose administered, Cmax (median, 1032 ng/mL; range, 576-1766) and AUC0-24 (median, 63.9 µg/mL*min; range, 42.4-152.4) were greater after single oral administration of NOV than REF (282.7 ng/mL; range, 94.8-390.2, and 319 23.8 µg/mL*min; range, 8.2-42.3, respectively; both P = .004). No differences were observed between products for absolute oral bioavailability (NOV 55% range, 15-88; REF 17% range, 10-77; P = .25). Treatment with both preparations was associated with reduced gastric squamous ulcer scores and increased pH of gastric fluid. Bioequivalence was demonstrated for pharmacodynamic measures with the exception of % time pH <4, despite differences in dose rate and subsequent plasma omeprazole concentrations. CONCLUSIONS AND CLINICAL IMPORTANCE: The findings of this study indicate that the NOV product would be a suitable alternative to the reference product, and confirm that plasma concentrations of omeprazole and omeprazole dose do not predict drug pharmacodynamics in horses.


Subject(s)
Anti-Ulcer Agents , Horse Diseases , Stomach Ulcer , Administration, Oral , Animals , Anti-Ulcer Agents/pharmacology , Anti-Ulcer Agents/therapeutic use , Cross-Over Studies , Female , Horse Diseases/drug therapy , Horses , Omeprazole/pharmacology , Omeprazole/therapeutic use , Prospective Studies , Stomach Ulcer/drug therapy , Stomach Ulcer/veterinary
5.
J Vet Intern Med ; 34(6): 2719-2726, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32990384

ABSTRACT

BACKGROUND: Intragastric pH profiles of neonatal foals admitted to the intensive care unit (ICU) remain poorly characterized. HYPOTHESIS/OBJECTIVES: To determine intragastric pH profiles and clinical parameters associated with intragastric pH in foals admitted to the ICU. ANIMALS: Forty-two neonatal foals admitted to the ICU and requiring placement of an indwelling nasogastric tube for nutritional management were included. METHODS: Intragastric pH was measured for 24 hours from the time of admission. Mean pH, % time pH <4, and % time pH >4 were determined for each foal. History, clinical findings, and clinicopathological data recorded at the time of presentation were collected. RESULTS: The mean pH of included foals was 5.5 ± 1.8. The median % time pH <4 was 6.3% (range: 0-99). A history of placentitis was associated with greater mean pH (median 5.3 (range: 0.9-7.8) versus median 7.2 (5.9-11.3); P = .002) and less % time pH <4 (median 13 (0-99.6) versus median 0.1 (0-7.2); P = .01). Foals with diarrhea had a greater % time pH <4 (median 4.6% (0-99) versus median 28.8% (1.4-57.48); P = .02). Foals with a pH >4 for >50% recording time had a lower PaO2 (mean difference 25.0 mm Hg; 95% confidence interval [CI], 14.4-35.6; P = .03) and higher PaCO2 (mean difference 14.9 mm Hg; 95% CI, 4.7-25.2; P = .02). Surviving foals had a lower mean median hourly pH (P = .02). CONCLUSIONS AND CLINICAL IMPORTANCE: Intragastric pH profiles were unpredictable and mostly >4 for >80% of the recording time. This study does not support the indiscriminate administration of acid suppressive treatment.


Subject(s)
Horse Diseases , Hospitalization , Animals , Animals, Newborn , Horse Diseases/therapy , Horses , Hydrogen-Ion Concentration , Intensive Care Units
SELECTION OF CITATIONS
SEARCH DETAIL